When citing an abstract from the 2009 Annual - Society for ...

More documents

Recommendations

Info

Poster 529. Treatments: Alzheimer's and Neurodegeneration Location: South Hall A Time: Tuesday, October 20, 2009, 8:00 am - 12:00 noon Program#/Poster#: 529.3/I28 Topic: C.02.o. Therapies Support: ADRC grant P50AG025711 Funds from the Byrd Institute Title: The therapeutic effects of caffeine and coffee in Alzheimer’s disease Authors: *C. CAO 1 , X. LIN 1 , L. WANG 2 , M. MAMCARZ 2 , M. RUNFELDT 1 , G. W. ARENDASH 2 ; 1 Mol. Pharmacol. and Physiol., 2 Biol., Univ. of South Florida, Tampa, FL Abstract: The premise that caffeine/coffee may provide a safe, effective, readily available, and inexpensive therapeutic against Alzheimer’s Disease (AD) is underscored by a growing body of epidemiologic literature showing protective effects against memory impairment and AD. For example, mid-life coffee consumption has been linked to a 65% decreased risk of AD. Our own work in AD transgenic mice has shown that caffeine both protects against and reverses cognitive impairment by directly affecting Aβ pathogenesis. To determine the extent to which noncaffeinergic components of coffee may be involved in the cognitive benefits of coffee, we have conducted a long-term study involving three months daily treatment by gavage with regular coffee or decaffeinated coffee to APP/PS1 (Tg) mice. Both coffee and decaffeinated coffee were prepared in the same way and the caffeine concentration of each was measured before administrated. Behavior testing near the end of the treatment period revealed that coffee treated Tg mice had significantly improved working memory compared to control Tg mice. By contrast, the decaffeinated coffee treatment group of Tg mice exhibited no such beneficial effects. Plasma cytokine analysis nonetheless indicated that both caffeine and non-caffeinergic compounds in coffee can provide beneficial effects and act synergistically. We also analyzed 208 human plasma samples for caffeine levels from two clinical sites of the Florida Alzheimer’s Disease Research Center (119 from Miami and 89 from Tampa), divided into AD, MCI and normal aged individuals. Our result show that spontaneous caffeine levels in normal aged subject are significantly higher than AD subjects at the Tampa site, but no significant difference compared with MCI, while caffeine levels in normal is higher than MCI and AD in subjects at the Miami site. Thus, our results from both animal studies and human habitual caffeine intake show a consistent association of caffeine with normal or maintained cognitive function. Additionally, in
oth AD Tg mice and young adult/aged humans, we find that blood Aβ levels are modified for hours following a single administration of caffeine or coffee. This is consistent with our previous data showing that caffeine can quickly and directly inhibit Aβ production. Our studies collectively suggest that maintenance of habitual coffee intake (around 5 cups per day) throughout adult hood is very important for prevention of AD development. Disclosures: C. Cao, None; X. Lin, None; L. Wang, None; M. Mamcarz, None; M. Runfeldt, None; G.W. Arendash, None. Poster 529. Treatments: Alzheimer's and Neurodegeneration Location: South Hall A Time: Tuesday, October 20, 2009, 8:00 am - 12:00 noon Program#/Poster#: 529.5/I29 Topic: C.02.o. Therapies Title: Treatment of Alzheimer's model mice with AMPK-activating drug, metformin Authors: *K. A. DITACCHIO 1 , R. R. NOFSINGER 2 , G. DZIEWCZAPOLSKI 1 , S. F. HEINEMANN 1 ; 1 Mol. Neurobio. Laboratory-Heinemann, The Salk Insitute, La Jolla, CA; 2 Gene Expression Laboratory-Evans, The Salk Inst., La Jolla, CA Abstract: Epidemiological studies in human patients suggest that exercise may delay the progression of Alzheimer’s disease (AD), while studies in animals additionally support caloric restriction as protective. Both of these interventions create a shortage of cellular energy whereby available ATP is converted to AMP and the AMP-activated protein kinase (AMPK) is activated. While the role of AMPK activation has been well established under these conditions, its function in the progression of AD has been neglected. To address this, we have used the AMPKactivating drug, metformin, in an attempt to pharmacologically mimic conditions that are thought to be protective in AD. Mice were treated for six months with metformin in their drinking water at 2mg/ml resulting in consumption of ~300mg/kg/day. Here we show surprising alteration to the progression of Alzheimer’s-like phenotypes in APP transgenic mice following this treatment with potentially important consequences for human patients. Disclosures: K.A. DiTacchio, None; R.R. Nofsinger, None; G. Dziewczapolski, None; S.F. Heinemann, None.
Page 1 and 2:
When citing an abstract from the 20
Page 3 and 4:
specification. Supported by the NIH
Page 5 and 6:
Poster 505. Cell Lineage and Cell F
Page 7 and 8:
Location: South Hall A Time: Tuesda
Page 9 and 10:
mammalian Suppressor of Hairless (R
Page 11 and 12:
Abstract: In spite of the considera
Page 13 and 14:
Abstract: The dorsal root ganglia (
Page 15 and 16:
Genome Canada Title: Pannexin 2, a
Page 17 and 18:
Authors: *T. ROITBAK, L. A. CUNNING
Page 19 and 20:
never express mature neuronal genes
Page 21 and 22:
NIH Neuroscience Blueprint Title: A
Page 23 and 24:
1 Dept. of Anatomy, Ajou Univ. Sch.
Page 25 and 26:
Poster 506. Neurogenesis II Locatio
Page 27 and 28:
from ND7 cells, showed an increase
Page 29 and 30:
functions of the NZF/MyTgene family
Page 31 and 32:
NIH T32 MH018268-24 Solnit Integrat
Page 33 and 34:
pathway and its transient transloca
Page 35 and 36:
(82±12%) in the number of GABAergi
Page 37 and 38:
constructs were tagged with or coin
Page 39 and 40:
Title: How do GFAP-expressing neura
Page 41 and 42:
Disclosures: A. Pignatelli, None; J
Page 43 and 44:
Page 45 and 46:
Disclosures: J.H. Lim, None; S.D. M
Page 47 and 48:
Poster 507. Stem Cells: Basic Biolo
Page 49 and 50:
significant changes in gene express
Page 51 and 52:
embryonic period of rat corticogene
Page 53 and 54:
PRIN 2005 Title: Death resistant ne
Page 55 and 56:
Topic: A.03.b. Stem cells: Basic bi
Page 57 and 58:
during development as well as betwe
Page 59 and 60:
fate of MAPCs within the CNS is not
Page 61 and 62:
Torsten and Ragnar Söderberg’s F
Page 63 and 64:
Support: FNRS - Belgium Title: Prob
Page 65 and 66:
Inserm Osteoarticular research gran
Page 67 and 68:
animals (p
Page 69 and 70:
Abstract: Currently there are no ef
Page 71 and 72:
Time: Tuesday, October 20, 2009, 8:
Page 73 and 74:
Poster 508. Development and Organiz
Page 75 and 76:
Poster 508. Development and Organiz
Page 77 and 78:
Disclosures: M. Nebieridze , None;
Page 79 and 80:
Disclosures: Y. Kim, None; R. Sincl
Page 81 and 82:
Disclosures: A. Haessly, None; B. S
Page 83 and 84:
the connection at the level of the
Page 85 and 86:
due to a per- or post-synaptic func
Page 87 and 88:
suggest that ambient temperature ma
Page 89 and 90:
509. Molecular Mechanisms Regulatin
Page 91 and 92:
stationary neurons, the migration s
Page 93 and 94:
Ser473 and Thr308 in the null cereb
Page 95 and 96:
maintained in culture in medium sup
Page 97 and 98:
development, may alter the proper m
Page 99 and 100:
Program#/Poster#: 510.2/B35 Topic:
Page 101 and 102:
Poster 510. Regeneration: PNS Locat
Page 103 and 104:
Disclosures: D. Wu , None; A. Raafa
Page 105 and 106:
Disclosures: R.M. Grumbles, None; C
Page 107 and 108:
ody response, but interfered with a
Page 109 and 110:
properties of sensory nerve grafts.
Page 111 and 112:
510. Regeneration: PNS Location: So
Page 113 and 114:
domains that are known to promote c
Page 115 and 116:
Support: CIHR AHFMR Title: Side-to-
Page 117 and 118:
Disclosures: X. Jing, None; T. Wang
Page 119 and 120:
development and has been implicated
Page 121 and 122:
Abstract: Peripheral nerve gaps tha
Page 123 and 124:
Program#/Poster#: 510.23/B56 Topic:
Page 125 and 126:
Poster 510. Regeneration: PNS Locat
Page 127 and 128:
promote the elongation of intact ne
Page 129 and 130:
examined the consequences on axonal
Page 131 and 132:
using co-immunoprecipitation and di
Page 133 and 134:
Abstract: A hallmark feature of NMD
Page 135 and 136:
not by AMPA stimulation. Importantl
Page 137 and 138:
phosphorylation site. We have gener
Page 139 and 140:
damage has been reported to be a co
Page 141 and 142:
have not been found previously in c
Page 143 and 144:
Abstract: In the barrel cortex, fee
Page 145 and 146:
Authors: *H. MAEJIMA 1 , S. SAKANO
Page 147 and 148:
Poster 511. Glutamate Receptors: Ge
Page 149 and 150:
Page 151 and 152:
indicating the presence of the two
Page 153 and 154:
significance of the structure of Gl
Page 155 and 156:
elicited by kainate and glutamate,
Page 157 and 158:
the GluRdelta2 receptor in the lurc
Page 159 and 160:
mediated inhibition, generated by s
Page 161 and 162:
Page 163 and 164:
Poster 513. GABA-A Receptors: Physi
Page 165 and 166:
As etomidate concentrations increas
Page 167 and 168:
Authors: *J. ADAMS, T. G. SMART; Ne
Page 169 and 170:
Poster 513. GABA-A Receptors: Physi
Page 171 and 172:
Topic: B.02.o. GABA(A) receptors: P
Page 173 and 174:
Master scholarship CONACyT Title: M
Page 175 and 176:
Page 177 and 178:
these cells. α3KO mice showed an e
Page 179 and 180:
Authors: *M. L. MCCRACKEN 1 , L. M.
Page 181 and 182:
514. Glycine Receptors Location: So
Page 183 and 184:
Poster 514. Glycine Receptors Locat
Page 185 and 186:
glycine induced chloride currents.
Page 187 and 188:
Authors: F. WELTZIEN 1 , I. PAARMAN
Page 189 and 190:
Program#/Poster#: 514.10/B117 Topic
Page 191 and 192:
occurs by interaction with splicing
Page 193 and 194:
Disclosures: Y. Kim, None; L.O. Tru
Page 195 and 196:
forebrain regions and that the α2
Page 197 and 198:
Abstract: The postnatal development
Page 199 and 200:
Program#/Poster#: 515.1/C1 Topic: B
Page 201 and 202:
Disclosures: C. Tai, None; B.A. Mac
Page 203 and 204:
this is indicative of changes in tw
Page 205 and 206:
NISWENDER 1 , C. D. WEAVER 3 , C. W
Page 207 and 208:
Program#/Poster#: 515.8/C8 Topic: B
Page 209 and 210:
Poster 515. Muscarinic Receptors Lo
Page 211 and 212:
515. Muscarinic Receptors Location:
Page 213 and 214:
(OxoM) was significantly greater in
Page 215 and 216:
phosphorylation, microdialysis and
Page 217 and 218:
516. Serotonin Receptors II Locatio
Page 219 and 220:
5-HT1A signaling pathways and mecha
Page 221 and 222:
produced a similar phenotype to tra
Page 223 and 224:
1 2 Dept Woman Child Hlth., Karolin
Page 225 and 226:
Poster 516. Serotonin Receptors II
Page 227 and 228:
to be formed in order to allow Gi/o
Page 229 and 230:
TPH1 & 2 knockout mice. Another imp
Page 231 and 232:
several behaviors in rodents report
Page 233 and 234:
NIH Grant DA025412 ACADIA Pharmaceu
Page 235 and 236:
Poster 516. Serotonin Receptors II
Page 237 and 238:
pattern congaing). Results were the
Page 239 and 240:
Abstract: Serotonin receptors in pr
Page 241 and 242:
Topic: B.04.a. Sodium channels: Phy
Page 243 and 244:
persistent sodium current is engage
Page 245 and 246:
Authors: J.-H. WANG 1 , *N. CHEN 2
Page 247 and 248:
Given the fact that the AIS of moto
Page 249 and 250:
517. Sodium Channels: Physiology II
Page 251 and 252:
hyperpolarized resting membrane pot
Page 253 and 254:
with longer pulses. Macroscopic ina
Page 255 and 256:
Support: Brain Research Trust Medic
Page 257 and 258:
Page 259 and 260:
Poster 517. Sodium Channels: Physio
Page 261 and 262:
channels activity at 2 mM Ca 2+ rev
Page 263 and 264:
Title: The effect of 1-octanol on s
Page 265 and 266:
NIH Grant 1F31NS059190 NIH Grant T3
Page 267 and 268:
change alters CaV3.2 gating and act
Page 269 and 270:
secondary dendrites. Ratiometric im
Page 271 and 272:
Program#/Poster#: 518.10/C64 Topic:
Page 273 and 274:
AA016852 AA017048 Title: Acute effe
Page 275 and 276:
tools capable of distinguishing amo
Page 277 and 278:
the most common mechanisms of chann
Page 279 and 280:
Program#/Poster#: 519.3/C72 Topic:
Page 281 and 282:
Title: Neurofibromin, CRMP-2 and pr
Page 283 and 284:
Poster 519. Voltage-Dependent Calci
Page 285 and 286:
IHCs or OHCs but may rather be caus
Page 287 and 288:
Abstract: Voltage-gated calcium (Ca
Page 289 and 290:
Support: NS029967 Title: Isoform-sp
Page 291 and 292:
Page 293 and 294:
cells. The most prominent RIM1 effe
Page 295 and 296:
messengers. One is the chemically m
Page 297 and 298:
Abstract: A dominant form of presyn
Page 299 and 300:
CONACyT Title: Gating charges per c
Page 301 and 302:
US-Israel Binational Sci Fnd #20053
Page 303 and 304:
Disclosures: P.M. Paez, None; D.J.
Page 305 and 306:
variants. Therefore, the alternativ
Page 307 and 308:
the prediction is that a BK-like cu
Page 309 and 310:
Abstract: Modulation of ion channel
Page 311 and 312:
Authors: *E. PETROFF; Biol. and Mol
Page 313 and 314:
DNASTAR, Inc Title: Differential tr
Page 315 and 316:
520. Calcium-Activated Potassium Ch
Page 317 and 318:
of SK channels and had little effec
Page 319 and 320:
pathway, consisting of axons from l
Page 321 and 322:
Title: Loss of dendritic Ih results
Page 323 and 324:
Poster 521. Ion Channels and Diseas
Page 325 and 326:
causes pure familial hemiplegic mig
Page 327 and 328:
may involve spontaneously occuring
Page 329 and 330:
Abstract: Mutations in voltage-gate
Page 331 and 332:
Page 333 and 334:
facilitate efflux at a distance fro
Page 335 and 336:
Abstract: Voltage gated calcium cha
Page 337 and 338:
that this channel regulates the mor
Page 339 and 340:
Page 341 and 342:
521. Ion Channels and Disease Locat
Page 343 and 344:
These results indicate that neurona
Page 345 and 346:
ise to a reduced number of Kv1.1 su
Page 347 and 348:
Title: Cholesterol elevation impair
Page 349 and 350:
Poster 521. Ion Channels and Diseas
Page 351 and 352:
alterations in ion channel expressi
Page 353 and 354:
Abstract: Over the past 5 years an
Page 355 and 356:
Abstract: Glial-derived primary bra
Page 357 and 358:
Page 359 and 360:
fluorescent sensor that responds to
Page 361 and 362:
adjacent synapses and were subseque
Page 363 and 364:
Title: Photodamaging the ribbon dis
Page 365 and 366:
Program#/Poster#: 522.9/E34 Topic:
Page 367 and 368:
assembly, creating an energetic bar
Page 369 and 370:
dependent fusion of a SV. We optica
Page 371 and 372:
type of exocytotic vesicle and cell
Page 373 and 374:
Support: NIH Grant GM081809 NIH Gra
Page 375 and 376:
522. Neurtransmitter Release: Docki
Page 377 and 378:
labeling showed extensive co-locali
Page 379 and 380:
protein which is also implicated in
Page 381 and 382:
NINDS UO1-NS058213 NIDA P50DA005274
Page 383 and 384:
523. Modulation: Mechanisms of Acti
Page 385 and 386:
Poster 523. Modulation: Mechanisms
Page 387 and 388:
effect of the secondly applied drug
Page 389 and 390:
Abstract: Transient, non-catastroph
Page 391 and 392:
Page 393 and 394:
523. Modulation: Mechanisms of Acti
Page 395 and 396:
sites, as it decreased the amplitud
Page 397 and 398:
Abstract: NMDA receptors are critic
Page 399 and 400:
Support: AHAF NIH Grant NS055804 Ti
Page 401 and 402:
524. LTP: Physiology and Behavior I
Page 403 and 404:
Moreover, the expression of some fo
Page 405 and 406:
mg/kg/day) or saline during 3 days
Page 407 and 408:
control levels in the presence of p
Page 409 and 410:
the novel object recognition task,
Page 411 and 412:
524. LTP: Physiology and Behavior I
Page 413 and 414:
stimulation of the contralateral CA
Page 415 and 416:
effects on cognitive functions, par
Page 417 and 418:
escaling and convergence to a commo
Page 419 and 420:
Abstract: We demonstrate here for t
Page 421 and 422:
Page 423 and 424:
input resistance (RN = 108.24 ± 20
Page 425 and 426:
nerve conduction block phenomenon,
Page 427 and 428:
Authors: *K. M. CRISP; St Olaf Col.
Page 429 and 430:
correlations and defined electrical
Page 431 and 432:
Authors: T. F. BECKHAUSER 1 , C. V.
Page 433 and 434:
Topic: C.02.n. Animal and experimen
Page 435 and 436:
Program#/Poster#: 526.4/G27 Topic:
Page 437 and 438:
different ages. Authors thank Dr. C
Page 439 and 440:
Abstract: The cholinergic neurotran
Page 441 and 442:
Topic: C.02.n. Animal and experimen
Page 443 and 444:
Support: Alzheimer's Association AP
Page 445 and 446:
Page 447 and 448:
2. Doraiswamy, P.M., et al. J Geron
Page 449 and 450:
excess of Aβ in the brain. We have
Page 451 and 452:
Authors: *S. M. KRANTIC 1 , W. YU 2
Page 453 and 454:
Disclosures: M. Lange, None; R. Sow
Page 455 and 456:
Poster 526. Alzheimer's Disease: Ex
Page 457 and 458:
sham and lesion groups were able to
Page 459 and 460:
e phagocytically compromised during
Page 461 and 462:
Alzheimer's Association IIRG-02-375
Page 463 and 464:
Disclosures: C. Perez Cruz, Abbott,
Page 465 and 466:
necessarily precede one to another.
Page 467 and 468:
Title: γ-Secretase activity altera
Page 469 and 470:
were elevated by treatment with the
Page 471 and 472: effects in the brain without any me
Page 473 and 474: Univ. of Maryland, College Park, MD
Page 475 and 476: membrane synthesis. For instance, d
Page 477 and 478: Program#/Poster#: 527.13/H26 Topic:
Page 479 and 480: Program#/Poster#: 527.15/H28 Topic:
Page 481 and 482: clarify its distribution in human t
Page 483 and 484: Topic: C.02.d. Beta and gamma secre
Page 485 and 486: Location: South Hall A Time: Tuesda
Page 487 and 488: Collectively, these findings, taken
Page 489 and 490: consolidated memories (remembering)
Page 491 and 492: plaque and tangle model (Bi-TAPP) w
Page 495 and 496: pattern reminiscent of our previous
Page 497 and 498: Authors: *N. W. SEEDS 1 , S. FABBRO
Page 499 and 500: Time: Tuesday, October 20, 2009, 8:
Page 501 and 502: learning performance in the Morris
Page 503 and 504: immunoprecipitation/Western blottin
Page 505 and 506: Authors: *L. F. YAMASHITA, A. A. BO
Page 507 and 508: AG10688 Title: Neuronal colocalizat
Page 509 and 510: Disclosures: M.A. King, None; M.L.
Page 511 and 512: in the compromised cerebral vascula
Page 513 and 514: cognition has come from transgenic
Page 515 and 516: Support: NIH Grant RO1 AG20159 Titl
Page 519 and 520: were down-regulated. In contrast, g
Page 521: Title: Nicotine treatment of mild c
Page 525 and 526: Poster 529. Treatments: Alzheimer's
Page 527 and 528: excised 30 minutes and 3 hours afte
Page 529 and 530: Authors: *C. HOLSCHER 1 , V. A. GAU
Page 533 and 534: inhibit the protective action of AP
Page 535 and 536: of connectivity among neurons resul
Page 537 and 538: Title: Addressing the challenge of
Page 543 and 544: Disclosures: L.J. Street, None; S.
Page 545 and 546: significantly. When the nitrites le
Page 547 and 548: absence of vision. The present stud
Page 549 and 550: Title: PIB binding in Parkinson dis
Page 553 and 554: cortex, pre-supplementary motor are
Page 555 and 556: aetiology of VH in PD is unknown .H
Page 557 and 558: Employment (full or part-time); U.
Page 559 and 560: neurons. These results suggest that
Page 561 and 562: long-term levodopa therapy. It has
Page 563 and 564: Time: Tuesday, October 20, 2009, 8:
Page 565 and 566: a 6 h period by a neurologist blind
Page 567 and 568: Program#/Poster#: 530.19/J29 Topic:
Page 569 and 570: eductions, respectively, in LID to
Page 571 and 572: Authors: *E. L. PRANSKI, N. V. DALA
Page 573 and 574:
530. Parkinson's Disease: Human Rel
Page 575 and 576:
console, CE was measured into 5 con
Page 577 and 578:
Support: NIH Grant 5T32GM007507 NIH
Page 579 and 580:
deficiency leads specifically to ta
Page 581 and 582:
months of age, with no differences
Page 583 and 584:
Title: Dietary selenium deficiency
Page 585 and 586:
Page 587 and 588:
have greater autoreceptor inhibitio
Page 589 and 590:
DFG Transregio SFB TR3 A11 and D12
Page 591 and 592:
poorly ubiquitinated when compared
Page 593 and 594:
using the “tet-off” system. Whe
Page 595 and 596:
Topic: C.03.d. Transgenic and relat
Page 597 and 598:
531. Parkinson's Disease: Models II
Page 599 and 600:
Poster 531. Parkinson's Disease: Mo
Page 601 and 602:
Disclosures: M. Herzig, None; P. Sc
Page 603 and 604:
oxygen species in neurons is preven
Page 605 and 606:
Perugia, Perugia, Italy; 4 Ctr. of
Page 607 and 608:
Topic: C.03.f. Mechanisms and degen
Page 609 and 610:
Page 611 and 612:
Poster 532. Parkinson's Disease: Ra
Page 613 and 614:
(100µg/50µl) or cyRADfV (negative
Page 615 and 616:
Abstract: The inferior colliculus (
Page 617 and 618:
Program#/Poster#: 532.14/L2 Topic:
Page 619 and 620:
Disclosures: K.B. Dupre, None; K.L.
Page 621 and 622:
loss of DA neurons 10 months after
Page 623 and 624:
enhancer synphillin. We are current
Page 625 and 626:
Grad. Sch. of Science, Kyoto Univ.,
Page 627 and 628:
Page 629 and 630:
Page 631 and 632:
transiently reversed in DA-depleted
Page 633 and 634:
and by Filter-trap assays and FCS (
Page 635 and 636:
members of the Bcl-2 family. In add
Page 637 and 638:
Biomedicine and Dept. of Biochem.,
Page 639 and 640:
Title: Pathogenic mechanism and sma
Page 641 and 642:
Abstract: Huntington’s disease (H
Page 643 and 644:
Authors: *M. SHIMOJO; Univ. Kentuck
Page 645 and 646:
Program#/Poster#: 533.13/L28 Topic:
Page 647 and 648:
Poster 533. Huntington's Disease an
Page 649 and 650:
iochemical properties. To further v
Page 651 and 652:
aberrant chromatin remodeling is a
Page 653 and 654:
oligomeric or protofibrillar forms
Page 655 and 656:
neurodegeneration in the striatum a
Page 657 and 658:
study of HD is how this polyQ-expan
Page 659 and 660:
Title: Androgen receptor antagonist
Page 661 and 662:
Program#/Poster#: 533.28/M5 Topic:
Page 663 and 664:
Disclosures: R. Schneider, None; A.
Page 665 and 666:
Disclosures: S.J. Bissel, None; G.
Page 667 and 668:
duodenal epithelium to the blood st
Page 669 and 670:
Authors: *D. GRIS 1 , Z. YE 1 , H.
Page 671 and 672:
1 2 3 Physiol., Univ. of Toronto, T
Page 673 and 674:
Pioneer Fund Title: Induction of au
Page 675 and 676:
Disclosures: B.A. Faucheux, None; J
Page 677 and 678:
mTOR activation. Since STI1 has imp
Page 679 and 680:
Authors: *A. BACHIS 1 , V. AVDOSHIN
Page 681 and 682:
Authors: *S. G. KOHAMA 1 , S. G. KR
Page 683 and 684:
Poster 535. Aging of the Nervous Sy
Page 685 and 686:
Abstract: Oxidative stress is assoc
Page 687 and 688:
Page 689 and 690:
Program#/Poster#: 535.8/M30 Topic:
Page 691 and 692:
Title: 13C isotopic incorporation s
Page 693 and 694:
Page 695 and 696:
patent or other intellectual proper
Page 697 and 698:
Abstract: The serotonergic system i
Page 699 and 700:
Disclosures: M.C. Mitschelen, None;
Page 701 and 702:
ml water/day. Results: A multivaria
Page 703 and 704:
Abstract: Neurodegenerative disorde
Page 705 and 706:
Authors: *G. L. BECKER 1 , P. J. HU
Page 707 and 708:
RESNICK 1 ; 1 Natl. Inst. On Aging/
Page 709 and 710:
Disclosures: D.H. Salat, None; S.Y.
Page 711 and 712:
Page 713 and 714:
Disclosures: B. Setlow, None; D.S.
Page 715 and 716:
Disclosures: B. Levant, Friesland F
Page 717 and 718:
Disclosures: K. Hashimoto-Torii, No
Page 719 and 720:
Abstract: Methylphenidate (MPH) tre
Page 721 and 722:
Page 723 and 724:
and examined the function of STRAD
Page 725 and 726:
Fédération des Maladies Orpheline
Page 727 and 728:
above are either absent or altered
Page 729 and 730:
NSF predoctoral fellowship Title: L
Page 731 and 732:
Topic: C.06.k. Animal models and me
Page 733 and 734:
NARSAD, B. Research Grant (principa
Page 735 and 736:
neuropathology in these human devel
Page 737 and 738:
Abstract: Determining the timing of
Page 739 and 740:
Topic: C.06.d. Developmental disord
Page 741 and 742:
mTOR hyperactivity at the cellular
Page 743 and 744:
Authors: *K. E. WATKINS 1 , N. A. B
Page 745 and 746:
Program#/Poster#: 537.3/O3 Topic: C
Page 747 and 748:
p=0.43) with converging values in t
Page 749 and 750:
Topic: C.06.j. ADHD, SLI, dyslexia
Page 751 and 752:
Dcdc2 in mice, behavioral features
Page 753 and 754:
the role for this gene in the etiol
Page 755 and 756:
Page 757 and 758:
examining functional-anatomic devel
Page 759 and 760:
inhibit on 50% of stop-trials. Stop
Page 761 and 762:
Support: Finnish Cultural Foundatio
Page 763 and 764:
Poster 537. Developmental Disorders
Page 765 and 766:
stimulus. In our fMRI design, prosa
Page 767 and 768:
Killam scholarship NSERC scholarshi
Page 769 and 770:
Topic: C.07.j. Animal models Suppor
Page 771 and 772:
538. Epilepsy: Inflammation and Imm
Page 773 and 774:
538. Epilepsy: Inflammation and Imm
Page 775 and 776:
different brain regions. This study
Page 777 and 778:
pilocarpine-induced SE leads to hip
Page 779 and 780:
pilocarpine induces prolonged SE re
Page 781 and 782:
NS051445-04 Title: Increased incide
Page 783 and 784:
Poster 539. Epilepsy: Anticonvulsan
Page 785 and 786:
(dentate gyrus subfield) hippocampu
Page 787 and 788:
Authors: *T. M. WYCKHUYS 1 , P. BOO
Page 789 and 790:
Page 791 and 792:
Page 793 and 794:
(saline, 0.2 mls, i.p.), LY379268 (
Page 795 and 796:
Authors: *K. K. AKULA 1 , S. K. KUL
Page 797 and 798:
Page 799 and 800:
ecto-ATPase inhibitor ARL 67156. In
Page 801 and 802:
protected confirming the anticonvul
Page 803 and 804:
NIH Grants R01NS048216 AHA Establis
Page 805 and 806:
Page 807 and 808:
Poster 540. Ischemia: Glia Location
Page 809 and 810:
dependent degradation of spectrin w
Page 811 and 812:
Abstract: CD36, a multi-functional
Page 813 and 814:
Title: Different mononuclear cell p
Page 815 and 816:
Page 817 and 818:
Disclosures: C.C. Pegg, None; M.A.
Page 819 and 820:
show that DHPG activates extracellu
Page 821 and 822:
Abstract: Ethyl pyruvate (EP), a si
Page 823 and 824:
Title: The relative roles of neuron
Page 825 and 826:
Page 827 and 828:
2 Wilke et al., 2004, J Neuropathol
Page 829 and 830:
attentional lapses, and depressed m
Page 831 and 832:
Program#/Poster#: 541.1/R4 Topic: C
Page 833 and 834:
performance, evolving white matter
Page 835 and 836:
within these networks between healt
Page 837 and 838:
Support: The Rockefeller University
Page 839 and 840:
and ROI analyses revealed no areas
Page 841 and 842:
Support: JIEDDO-001 Mid-Atlantic MI
Page 843 and 844:
diminished overall capacity to inte
Page 845 and 846:
DOD PT075675 Marshall Goldberg Fund
Page 847 and 848:
Poster 542. Spinal Cord Injury: Fro
Page 849 and 850:
indicate that acupuncture significa
Page 851 and 852:
einnervate their distal targets. To
Page 853 and 854:
Page 855 and 856:
Disclosures: S. Veiga, None; K. Irv
Page 857 and 858:
Blood β-hydroxybutyrate levels of
Page 859 and 860:
NIH Grant NS31193 New York State Co
Page 861 and 862:
Page 863 and 864:
EMG, trains of motor unit potential
Page 865 and 866:
the area of residual myelin in the
Page 867 and 868:
upregulation of genes in the A-HX g
Page 869 and 870:
carried out to confirm differences
Page 871 and 872:
Program#/Poster#: 542.23/T2 Topic:
Page 873 and 874:
of damage across spinal sections th
Page 875 and 876:
physiologic characteristics they sh
Page 877 and 878:
Page 879 and 880:
Page 881 and 882:
Disclosures: A. Jayaraman, None; J.
Page 883 and 884:
plasticity, we also tested E2’s a
Page 885 and 886:
Abstract: The 'Progesterone in Brai
Page 887 and 888:
Topic: C.11.h. Neuroprotective mech
Page 889 and 890:
543. Cell Death Mechanisms; Mitocho
Page 891 and 892:
Disclosures: C.C. Aguirre, None; A.
Page 893 and 894:
low doses (Ec50 less than 5nM), esp
Page 895 and 896:
Abstract: We reported before that 1
Page 897 and 898:
Authors: *K. D. YI, J. W. SIMPKINS;
Page 899 and 900:
Authors: L. XIE, E. POTEET, W. LI,
Page 901 and 902:
against cognitive decline and memor
Page 903 and 904:
and mitochondrial function are esse
Page 905 and 906:
Page 907 and 908:
vesicles, broken and disorganized c
Page 909 and 910:
Abstract: Increasing evidence sugge
Page 911 and 912:
Poster 544. Neurotoxicity: Toxins I
Page 913 and 914:
ain after i.m. injection. The highl
Page 915 and 916:
Support: FCT- Grant POCI/SAU-FCF/58
Page 917 and 918:
Poster 544. Neurotoxicity: Toxins I
Page 919 and 920:
Results revealed DAT complexes pres
Page 921 and 922:
Title: D. melanogaster: A new model
Page 923 and 924:
Support: NIH Grant P20 RR16454 USAM
Page 925 and 926:
Support: Department of Chemistry WS
Page 927 and 928:
Title: The striatal neurokinin-1 an
Page 929 and 930:
visualized using fluorescent phallo
Page 931 and 932:
Authors: *A. C. VALENCIA 1 , J. MOR
Page 933 and 934:
Support: NIH/NIA/IRP FAPESP Brazil
Page 935 and 936:
FONDECYT Grant 1090353 Title: Diffe
Page 937 and 938:
Page 939 and 940:
endothelial interactions. This will
Page 941 and 942:
of CD200 in immune-regulation and d
Page 943 and 944:
temporal concentration increases of
Page 945 and 946:
Alzheimer’s Association (KA) AG24
Page 947 and 948:
Page 949 and 950:
Topic: C.11.m. Neuroinflammation: C
Page 951 and 952:
Disclosures: R.F. Silva, None; S.L.
Page 953 and 954:
vessels in the neonatal mouse brain
Page 955 and 956:
death within 24 hours. This charact
Page 957 and 958:
(bDC). These bDCs share a remarkabl
Page 959 and 960:
proliferation. It is now evident th
Page 961 and 962:
Abstract: Negative symptoms (avolit
Page 963 and 964:
546. Schizophrenia and Bi-polar Dis
Page 965 and 966:
Poster 546. Schizophrenia and Bi-po
Page 967 and 968:
Authors: *M. S. MILELLA, F. PASSARE
Page 969 and 970:
Page 971 and 972:
mice. EGR-1 protein levels were ele
Page 973 and 974:
Abstract: α2 norepinephrine (NE) r
Page 975 and 976:
psychotic symptoms with PPI impairm
Page 977 and 978:
startle response were examined betw
Page 979 and 980:
Topic: C.15.d. Animal models Suppor
Page 981 and 982:
Page 983 and 984:
antagonist MLA (0.1 mM; 0.5µL), si
Page 985 and 986:
that these Nf1+/- RGC phenotypes re
Page 987 and 988:
cell-cell integrity, DNA fragmentat
Page 989 and 990:
found a significant decrease in pro
Page 991 and 992:
subcellular localization during a c
Page 993 and 994:
Authors: *D. BUCHMAN, J. ILLES; Med
Page 995 and 996:
Poster 548. Mood Disorders: Human B
Page 997 and 998:
Authors: *A. J. HOLMES 1 , R. BOGDA
Page 999 and 1000:
Support: KAKENHI (20790841) Title:
Page 1001 and 1002:
Program#/Poster#: 548.8/W26 Topic:
Page 1003 and 1004:
Page 1005 and 1006:
together, this study demonstrates t
Page 1007 and 1008:
depressed compared to nondepressed
Page 1009 and 1010:
1 Dept of Biol. Res., Lundbeck Res.
Page 1011 and 1012:
Disclosures: C.H. Duman, None; M. B
Page 1013 and 1014:
egulatory effects including glucose
Page 1015 and 1016:
Topic: C.16.f. Mood disorders: Expe
Page 1017 and 1018:
Page 1019 and 1020:
Disclosures: U.C. Campbell, None; S
Page 1021 and 1022:
eward-related effects of the TRI, D
Page 1023 and 1024:
Authors: E. ZHANG 1 , R. C. C. CHAN
Page 1025 and 1026:
Title: Neuroplastic changes associa
Page 1027 and 1028:
Poster 549. Mood Disorders: Experim
Page 1029 and 1030:
fluoxetine. No significant changes
Page 1031 and 1032:
Title: Peripheral infusion of the p
Page 1033 and 1034:
Abstract: In recent years it has be
Page 1035 and 1036:
Topic: C.17.bb. Neural plasticity,
Page 1037 and 1038:
increased AMPA/NMDA ratio with prol
Page 1039 and 1040:
nucleus accumbens (NAc) and the ext
Page 1041 and 1042:
Disclosures: B.A. Grueter, None; R.
Page 1043 and 1044:
electrophysiological experiments sh
Page 1045 and 1046:
IL; 3 Psychiatry, Yale Univ. Sch. o
Page 1047 and 1048:
550. Neural Plasticity, Dependence,
Page 1049 and 1050:
Disclosures: Z.R. Daruwalla, None;
Page 1051 and 1052:
development or expression of behavi
Page 1053 and 1054:
Fondation pour la Recherche Medical
Page 1055 and 1056:
550. Neural Plasticity, Dependence,
Page 1057 and 1058:
Poster 550. Neural Plasticity, Depe
Page 1059 and 1060:
persistence of these neuroadaptatio
Page 1061 and 1062:
Title: Toluene intoxication: Struct
Page 1063 and 1064:
Program#/Poster#: 551.1/Y4 Topic: C
Page 1065 and 1066:
highest dose of cocaine and ampheta
Page 1067 and 1068:
they had access to either a single
Page 1069 and 1070:
Abstract: Background: We have previ
Page 1071 and 1072:
Page 1073 and 1074:
Poster 551. Behavioral Pharmacology
Page 1075 and 1076:
each group), and the respective sur
Page 1077 and 1078:
adolescence with amphetamine demons
Page 1079 and 1080:
of CART mRNA levels in relation to
Page 1081 and 1082:
locomotor stimulation at low to mod
Page 1083 and 1084:
Abstract: It is well known that the
Page 1085 and 1086:
552. Alcohol: Neural Mechanisms II
Page 1087 and 1088:
Disclosures: Y. Chen, None; S.F. Le
Page 1089 and 1090:
educed basal glutamate levels (appr
Page 1091 and 1092:
Abstract: Poly-drug abuse may be pr
Page 1093 and 1094:
Title: Ethanol increases GAPDH-TIEG
Page 1095 and 1096:
Page 1097 and 1098:
expressing microglia (OX6) observed
Page 1099 and 1100:
consumption by C57Bl/6J mice. The r
Page 1101 and 1102:
Abstract: Ethanol may be consumed f
Page 1103 and 1104:
Page 1105 and 1106:
Poster 552. Alcohol: Neural Mechani
Page 1107 and 1108:
ain tissues of different treated gr
Page 1109 and 1110:
Authors: I. G. BARBOSA LUNA, J. M.
Page 1111 and 1112:
Topic: C.17.e. Alcohol: Neural mech
Page 1113 and 1114:
553. Cocaine, Methylphenidate, and
Page 1115 and 1116:
Poster 553. Cocaine, Methylphenidat
Page 1117 and 1118:
period rats were trained to self-ad
Page 1119 and 1120:
sodium butyrate injected immediatel
Page 1121 and 1122:
non-responders spent the majority o
Page 1123 and 1124:
Title: The effects of adrenalectomy
Page 1125 and 1126:
Program#/Poster#: 553.12/Z25 Topic:
Page 1127 and 1128:
NIH Grant R01 MH49469 NIH Grant F31
Page 1129 and 1130:
Disclosures: D.R. Ramirez, None; X.
Page 1131 and 1132:
at the basolateral amygdala (BLA).
Page 1133 and 1134:
Title: Sex differences in cocaine p
Page 1135 and 1136:
553. Cocaine, Methylphenidate, and
Page 1137 and 1138:
Disclosures: M.T. McCoy, Department
Page 1139 and 1140:
Abstract: Manganese enhanced magnet
Page 1141 and 1142:
Disclosures: T.Z. Ramsoy, None; K.S
Page 1143 and 1144:
and removal of the 22 N-terminal am
Page 1145 and 1146:
methamphetamine induced more extens
Page 1147 and 1148:
Page 1149 and 1150:
Disclosures: J. Nickell, None; A. V
Page 1151 and 1152:
Poster 554. Methamphetamine and Rel
Page 1153 and 1154:
Disclosures: K.A. Horner, None; Y.E
Page 1155 and 1156:
male and female CRF-R2 knockout (KO
Page 1157 and 1158:
Page 1159 and 1160:
Page 1161 and 1162:
The findings support the idea that
Page 1163 and 1164:
T32HL076133 Title: The acute effect
Page 1165 and 1166:
Abstract: Methamphetamine (METH) ab
Page 1167 and 1168:
Authors: *N. CAI, B. LADENHEIM, M.
Page 1169 and 1170:
Royal Gloden Jubilee PhD Program Ti
Page 1171 and 1172:
mediated by vasoactive eicosanoids.
Page 1173 and 1174:
Title: Dendrodendritic transmission
Page 1175 and 1176:
Page 1177 and 1178:
Page 1179 and 1180:
synapses between ET cells and GABAe
Page 1181 and 1182:
we demonstrate that the activation
Page 1183 and 1184:
had no consistent effect on mIPSCs
Page 1185 and 1186:
Authors: *N. KANG 1 , M. J. BAUM 2
Page 1187 and 1188:
NIH Grant DC006972 Title: The locat
Page 1189 and 1190:
Poster 555. Olfactory Bulb: Synapse
Page 1191 and 1192:
excitatory to inhibitory shift betw
Page 1193 and 1194:
ange of preferred AM frequencies de
Page 1195 and 1196:
Authors: *D. P. KNUDSEN 1 , T. Q. G
Page 1197 and 1198:
Title: Laminar dependent representa
Page 1199 and 1200:
Abstract: The auditory cortex is in
Page 1201 and 1202:
Page 1203 and 1204:
and savannah forest scenes (60 seco
Page 1205 and 1206:
consonant discriminations can be pe
Page 1207 and 1208:
Authors: *N. HIGGINS 1 , D. A. STOR
Page 1209 and 1210:
Title: Local field potentials and s
Page 1211 and 1212:
Title: Neuronal response latency an
Page 1213 and 1214:
Page 1215 and 1216:
Disclosures: J.M. Bouskila, None; M
Page 1217 and 1218:
favored the hypothesis that eCBs fu
Page 1219 and 1220:
1 2 3 Devers Eye Inst., Portland, O
Page 1221 and 1222:
Title: Tropisetron as a neuroprotec
Page 1223 and 1224:
Page 1225 and 1226:
premature ganglion cells. These res
Page 1227 and 1228:
Tectal EP amplitudes did not signif
Page 1229 and 1230:
esponses over time. The initial lig
Page 1231 and 1232:
Page 1233 and 1234:
amplitude is set by a balance of Ca
Page 1235 and 1236:
Kv4.2 was determined by immunohisto
Page 1237 and 1238:
Disclosures: H. Kim, None; J. Lee,
Page 1239 and 1240:
We have previously identified the c
Page 1241 and 1242:
Depolarizing a ‘donor’ cone eli
Page 1243 and 1244:
Title: The impact of temporal frequ
Page 1245 and 1246:
Poster 558. Visual Motion: Neural M
Page 1247 and 1248:
motion alone to that evoked by the
Page 1249 and 1250:
Support: NIH Grant AG17596 NIH Gran
Page 1251 and 1252:
Page 1253 and 1254:
Further, the central CCG peak was n
Page 1255 and 1256:
Authors: *Y. GU 1 , G. C. DEANGELIS
Page 1257 and 1258:
Poster 558. Visual Motion: Neural M
Page 1259 and 1260:
velocity signals are processed thro
Page 1261 and 1262:
model shows how vector decompositio
Page 1263 and 1264:
and whole-cell recordings. Tectal n
Page 1265 and 1266:
effector and object in a retinal fr
Page 1267 and 1268:
motion axis (George et al, 2002). I
Page 1269 and 1270:
Abstract: Motion aftereffects (MAE)
Page 1271 and 1272:
Topic: D.06.e. Pursuit Support: MRC
Page 1273 and 1274:
these changes in the symmetry of th
Page 1275 and 1276:
Authors: *C. J. COLLINS, R. ACKERLE
Page 1277 and 1278:
Poster 559. Pursuit Eye Movements L
Page 1279 and 1280:
task. While fixating a stationary s
Page 1281 and 1282:
559. Pursuit Eye Movements Location
Page 1283 and 1284:
suggest that NOT serves as an impor
Page 1285 and 1286:
eye position at the end of the sacc
Page 1287 and 1288:
To explicitly test the causal contr
Page 1289 and 1290:
Authors: *J. MARUTA 1 , M. SUH 2 ,
Page 1291 and 1292:
Page 1293 and 1294:
administration of BPN (100 ng/kg/2x
Page 1295 and 1296:
alter morphine-induced CPP and/or a
Page 1297 and 1298:
Topic: D.08.bb. Opioids Support: NI
Page 1299 and 1300:
greater than morphine. Of note, the
Page 1301 and 1302:
the possible relevance of the arach
Page 1303 and 1304:
560. Opioids: Mechanism of Action L
Page 1305 and 1306:
Poster 560. Opioids: Mechanism of A
Page 1307 and 1308:
560. Opioids: Mechanism of Action L
Page 1309 and 1310:
with either MOR (1 µg), FEN (1 ng)
Page 1311 and 1312:
Authors: A. DOGRUL 1 , *M. H. OSSIP
Page 1313 and 1314:
sensitive enough to demonstrate agi
Page 1315 and 1316:
Poster 560. Opioids: Mechanism of A
Page 1317 and 1318:
injected with CFA in the masseter a
Page 1319 and 1320:
Title: Effect of interleukin-8 rece
Page 1321 and 1322:
Page 1323 and 1324:
Poster 561. Neuropathic Pain: Infla
Page 1325 and 1326:
Clark AK, Yip PK, Grist J, Gentry C
Page 1327 and 1328:
all 10 baseline images before lamin
Page 1329 and 1330:
dorsal horn in models of pain creat
Page 1331 and 1332:
Authors: P. FELDMAN 1 , H. JUNG 2 ,
Page 1333 and 1334:
Page 1335 and 1336:
Topic: D.08.t. Mechanisms of neurop
Page 1337 and 1338:
Poster 561. Neuropathic Pain: Infla
Page 1339 and 1340:
Disclosures: T. Berta, None; Y. Liu
Page 1341 and 1342:
Disclosures: O. Rosenthal, Unilever
Page 1343 and 1344:
staircase procedure based on a two-
Page 1345 and 1346:
Abstract: The brain needs to encode
Page 1347 and 1348:
Program#/Poster#: 562.8/DD25 Topic:
Page 1349 and 1350:
562. Tactile Stimulation and Proces
Page 1351 and 1352:
Page 1353 and 1354:
Page 1355 and 1356:
compared to the evoked response to
Page 1357 and 1358:
Authors: *S. YEO 1,2 , I.-H. CHOE 3
Page 1359 and 1360:
Program#/Poster#: 562.19/DD36 Topic
Page 1361 and 1362:
week 1, 36±38% after week 2, 55±3
Page 1363 and 1364:
Morton Cure Paralysis Fund Title: A
Page 1365 and 1366:
Topic: D.10.a. Plasticity Support:
Page 1367 and 1368:
Page 1369 and 1370:
of hyperreflexia after SCI and open
Page 1371 and 1372:
Authors: *E. M. ANDREWS 1,2 , Q. F.
Page 1373 and 1374:
Page 1375 and 1376:
NeuN, calbindin (CB), neuron specif
Page 1377 and 1378:
and Synapsin-I proteins. The functi
Page 1379 and 1380:
well as in decerebrated cats by spi
Page 1381 and 1382:
Support: Canadian Institute of Heal
Page 1383 and 1384:
564. Rhythmic Movements: Afferent C
Page 1385 and 1386:
organization forms a potent and dur
Page 1387 and 1388:
antagonists to the rostral bath had
Page 1389 and 1390:
Page 1391 and 1392:
sensillae (CS). Two types of reacti
Page 1393 and 1394:
flexion signals from the tibia (Bä
Page 1395 and 1396:
Topic: D.11.d. Afferent control Sup
Page 1397 and 1398:
Poster 564. Rhythmic Movements: Aff
Page 1399 and 1400:
p0.05). To assess the CabPK influen
Page 1401 and 1402:
Program#/Poster#: 564.21/DD72 Topic
Page 1403 and 1404:
Page 1405 and 1406:
in behavioral experiments with inta
Page 1407 and 1408:
Abstract: A fundamental problem of
Page 1409 and 1410:
Page 1411 and 1412:
Topic: D.11.b. Connectivity Support
Page 1413 and 1414:
sustained activity pattern was corr
Page 1415 and 1416:
examine the organization of the ves
Page 1417 and 1418:
Support: CIHR 79416 Will-to-Win Sch
Page 1419 and 1420:
Poster 565. Rhythmic Motor Networks
Page 1421 and 1422:
document modulation of MIo neuron a
Page 1423 and 1424:
abuse also trigger the release of t
Page 1425 and 1426:
1 2 Behavioral Neurosci Br., NIDA,
Page 1427 and 1428:
Page 1429 and 1430:
566. Basal Ganglia: Transmitters an
Page 1431 and 1432:
dopaminergic cells in the posterior
Page 1433 and 1434:
Program#/Poster#: 566.11/EE26 Topic
Page 1435 and 1436:
Poster 566. Basal Ganglia: Transmit
Page 1437 and 1438:
Disclosures: T. Lerner, None; A.C.
Page 1439 and 1440:
Abstract: Cbln1 (precerebellin) is
Page 1441 and 1442:
Authors: S. TAI, *L. LEUNG; Univ. W
Page 1443 and 1444:
Topic: D.15.a. Transmitters and neu
Page 1445 and 1446:
Page 1447 and 1448:
Poster 567. Basal Ganglia: Electrop
Page 1449 and 1450:
external pallidum are known to exhi
Page 1451 and 1452:
nature of synchronous beta oscillat
Page 1453 and 1454:
Page 1455 and 1456:
smaller subset entrained to theta-b
Page 1457 and 1458:
Abstract: We have previously traine
Page 1459 and 1460:
Support: DA 06886 DA 04551 T32 Trai
Page 1461 and 1462:
Page 1463 and 1464:
and movement, using a paradigm desi
Page 1465 and 1466:
mechanism thought to prevent the br
Page 1467 and 1468:
A brain area that has been closely
Page 1469 and 1470:
Abstract: It is now widely believed
Page 1471 and 1472:
Authors: E. BRAZHNIK, I. AVILA, N.
Page 1473 and 1474:
Poster 567. Basal Ganglia: Electrop
Page 1475 and 1476:
chronic stroke. The present data su
Page 1477 and 1478:
controls its own load in maintainin
Page 1479 and 1480:
Topic: D.17.d. Stroke, damage, or d
Page 1481 and 1482:
task (0.11). There was a positive c
Page 1483 and 1484:
Res. Inst., Kyoto Univ., Inuyama, J
Page 1485 and 1486:
Poster 568. Stroke: Damage or Disea
Page 1487 and 1488:
glial (myoinositol, mIn), and gluta
Page 1489 and 1490:
Topic: D.17.d. Stroke, damage, or d
Page 1491 and 1492:
Page 1493 and 1494:
Disclosures: S. Churchill, None; D.
Page 1495 and 1496:
daily life. Although studies in hea
Page 1497 and 1498:
Abstract: Many activities of daily
Page 1499 and 1500:
Page 1501 and 1502:
These preliminary data suggests tha
Page 1503 and 1504:
568. Stroke: Damage or Disease - Me
Page 1505 and 1506:
Page 1507 and 1508:
final position. In contrast, the PO
Page 1509 and 1510:
Recently, the relationship between
Page 1511 and 1512:
Authors: E. CHANG 1 , *J. T. KING 2
Page 1513 and 1514:
Title: Retinoic acid stimulates est
Page 1515 and 1516:
Program#/Poster#: 569.7/EE98 Topic:
Page 1517 and 1518:
Disclosures: B.W. Bakkum, None; L.
Page 1519 and 1520:
specific to E2. In support, pharmac
Page 1521 and 1522:
not (reproductively-senescent). We
Page 1523 and 1524:
Topic: E.01.d. Steroids and plastic
Page 1525 and 1526:
Interestingly, none of these estrog
Page 1527 and 1528:
spatio-temporal subcellular distrib
Page 1529 and 1530:
Title: Maternal care and perinatal
Page 1531 and 1532:
Disclosures: K.M. Olesen, None; N.
Page 1533 and 1534:
Intriguingly, the autonomic respons
Page 1535 and 1536:
measured plasma norepinephrine (NE)
Page 1537 and 1538:
Authors: E. T. GILBREATH 1 , J. L.
Page 1539 and 1540:
Authors: *R. P. GAYKEMA, G. C. THAC
Page 1541 and 1542:
Support: NSERC Canadian Foundation
Page 1543 and 1544:
Page 1545 and 1546:
associated with differences in both
Page 1547 and 1548:
571. Parental Behavior Location: So
Page 1549 and 1550:
571. Parental Behavior Location: So
Page 1551 and 1552:
attained had over 10 times the numb
Page 1553 and 1554:
Page 1555 and 1556:
that this average round-the-clock m
Page 1557 and 1558:
maternal experience. Our preliminar
Page 1559 and 1560:
divergent paternal responses. P. ca
Page 1561 and 1562:
castration reduces the amount of hu
Page 1563 and 1564:
e related. In this study, sexually
Page 1565 and 1566:
Authors: *K. M. SEIP 1 , J. I. MORR
Page 1567 and 1568:
Authors: *D. POPA, E. BREEN, L. DUG
Page 1569 and 1570:
Topic: E.04.b. Respiratory regulati
Page 1571 and 1572:
Authors: N. R. NELSON 1 , *M. BEHAN
Page 1573 and 1574:
eceptor antagonists AP-5 and/or CNQ
Page 1575 and 1576:
Program#/Poster#: 572.9/FF14 Topic:
Page 1577 and 1578:
Page 1579 and 1580:
Disclosures: A.T. Takakura, None; M
Page 1581 and 1582:
dye “DiI” into the carotid body
Page 1583 and 1584:
Authors: J.-H. ZHANG 1,2 , S. J. FU
Page 1585 and 1586:
Support: NSERC Grant Department of
Page 1587 and 1588:
Page 1589 and 1590:
(WT) obtained from the same colony,
Page 1591 and 1592:
the activity of npEW-Ucn1 system du
Page 1593 and 1594:
defeated and instead exposed to emp
Page 1595 and 1596:
Title: Pre-locus coeruleus neurons
Page 1597 and 1598:
573. Stress-Modulated Brain Pathway
Page 1599 and 1600:
Poster 573. Stress-Modulated Brain
Page 1601 and 1602:
estraint stress starting one week p
Page 1603 and 1604:
increases VTA BDNF, which may influ
Page 1605 and 1606:
t=3.177, df=12). Early and delayed
Page 1607 and 1608:
CORT with the antagonist of GR or M
Page 1609 and 1610:
paradigm designed to induce variabl
Page 1611 and 1612:
Abstract: Neurogenesis in the hippo
Page 1613 and 1614:
Title: Chronic corticosterone expos
Page 1615 and 1616:
Program#/Poster#: 574.1/FF51 Topic:
Page 1617 and 1618:
574. Entrainment and Phase Shifts:
Page 1619 and 1620:
induced c-FOS cells was significant
Page 1621 and 1622:
Poster 574. Entrainment and Phase S
Page 1623 and 1624:
Ca2+i leak rate through RyR in vivo
Page 1625 and 1626:
neuroprotection or neuronal death.
Page 1627 and 1628:
phase to one that is consistent wit
Page 1629 and 1630:
Disclosures: N. Atkins, None; S. Re
Page 1631 and 1632:
Disclosures: L.S. Zhang , None; C.
Page 1633 and 1634:
of withdrawal from morphine, the bl
Page 1635 and 1636:
Title: Preliminary study of the exp
Page 1637 and 1638:
Page 1639 and 1640:
Page 1641 and 1642:
Similar to the results with clock g
Page 1643 and 1644:
investigation is necessary to ident
Page 1645 and 1646:
Poster 575. Maintenance and Executi
Page 1647 and 1648:
(color judgment) while at the same
Page 1649 and 1650:
Intelligence and Processing Speed c
Page 1651 and 1652:
Abstract: How the brain maintains s
Page 1653 and 1654:
MA; 2 The Picower Inst. for Learnin
Page 1655 and 1656:
Page 1657 and 1658:
Page 1659 and 1660:
The study proceeded in two stages.
Page 1661 and 1662:
NIH Grant AG0925 NSF Graduate Resea
Page 1663 and 1664:
Page 1665 and 1666:
eak, a surprising recognition task
Page 1667 and 1668:
Title: Behavioral and neural eviden
Page 1669 and 1670:
Topic: F.01.f. Working memory Suppo
Page 1671 and 1672:
Page 1673 and 1674:
perceived each odor contributed to
Page 1675 and 1676:
Program#/Poster#: 576.3/FF105 Topic
Page 1677 and 1678:
in the subliminal condition. These
Page 1679 and 1680:
with rPMC, and rPMC with rPC. There
Page 1681 and 1682:
premotor regions, but modulated mor
Page 1683 and 1684:
did not notice the delay. From this
Page 1685 and 1686:
Page 1687 and 1688:
evidence by influencing the represe
Page 1689 and 1690:
Authors: *R. M. KALWANI, J. I. GOLD
Page 1691 and 1692:
Results: RT for correct responses w
Page 1693 and 1694:
Title: Dissociable components of ob
Page 1695 and 1696:
Authors: *G. C. DE GUZMAN 1 , J. LA
Page 1697 and 1698:
Poster 577. Communication and Self:
Page 1699 and 1700:
esponse creation compared to contro
Page 1701 and 1702:
A Grant-in-Aid for Scientific Resea
Page 1703 and 1704:
Page 1705 and 1706:
egions previously implicated as the
Page 1707 and 1708:
NINDS grant NS048229-04 ONR Contrac
Page 1709 and 1710:
577. Communication and Self: Other
Page 1711 and 1712:
compared to that in the familiar fa
Page 1713 and 1714:
to make it possible to scan the bra
Page 1715 and 1716:
phylogenetically highly conserved n
Page 1717 and 1718:
Topic: F.01.l. Social cognition Sup
Page 1719 and 1720:
Support: CREST, 17022035 KAKENHI, 2
Page 1721 and 1722:
Poster 578. Executive Function: Ani
Page 1723 and 1724:
Disclosures: C.T. Miller, None; X.
Page 1725 and 1726:
Poster 578. Executive Function: Ani
Page 1727 and 1728:
trials were match trials and half w
Page 1729 and 1730:
Authors: *M. ISODA 1,2 , K. YAKO 1,
Page 1731 and 1732:
Page 1733 and 1734:
neural coding perspective the funct
Page 1735 and 1736:
induced cognitive impairments. Alth
Page 1737 and 1738:
Program#/Poster#: 579.6/GG21 Topic:
Page 1739 and 1740:
Poster 579. Executive Function: Rod
Page 1741 and 1742:
ehavioral and temporal information
Page 1743 and 1744:
ecause this ability in nonhuman ani
Page 1745 and 1746:
few information are available regar
Page 1747 and 1748:
Authors: *S. GARCIA, F. PAPALEO, L.
Page 1749 and 1750:
and cognitive flexibility occurs in
Page 1751 and 1752:
Title: Prenatal protein malnutritio
Page 1753 and 1754:
Employment (full or part-time); R.
Page 1755 and 1756:
correlates of behavioral performanc
Page 1757 and 1758:
Abstract: Like the proverbial moth
Page 1759 and 1760:
Support: Roche-Palo Alto Department
Page 1761 and 1762:
Page 1763 and 1764:
Page 1765 and 1766:
eward sensitivity. Results: BMI imp
Page 1767 and 1768:
1999). Here, we examined the time c
Page 1769 and 1770:
Support: NIH Grant MH48404 Pittsbur
Page 1771 and 1772:
Page 1773 and 1774:
Page 1775 and 1776:
581. Adult Neurogenesis and Cogniti
Page 1777 and 1778:
During neurogenesis, immature denta
Page 1779 and 1780:
training with the post-US cue was n
Page 1781 and 1782:
gross structural neurological chang
Page 1783 and 1784:
Authors: R. M. ALEKSEJEV 1 , *J. AM
Page 1785 and 1786:
Authors: *C. L. PICKENS 1 , T. ADAM
Page 1787 and 1788:
582. Stress and Behavior Location:
Page 1789 and 1790:
582. Stress and Behavior Location:
Page 1791 and 1792:
Support: HHMI (AMS) NIH Grant DA201
Page 1793 and 1794:
Program#/Poster#: 582.11/GG73 Topic
Page 1795 and 1796:
Poster 582. Stress and Behavior Loc
Page 1797 and 1798:
Poster 583. Reward: Motivated Behav
Page 1799 and 1800:
system. Ten healthy, normal-weight
Page 1801 and 1802:
medial shell amplify ‘liking’ r
Page 1803 and 1804:
Authors: *S. E. ROSS 1 , J. W. ALDR
Page 1805 and 1806:
Topic: F.03.a. Reward Support: NIH
Page 1807 and 1808:
Title: Activation of nucleus accumb
Page 1809 and 1810:
Page 1811 and 1812:
Disclosures: R. Sharf, None; M. Sar
Page 1813 and 1814:
Disclosures: M. Baudonnat, None; J.
Page 1815 and 1816:
RD for a block of trials. In the re
Page 1817 and 1818:
Abstract: Operant tasks have been u
Page 1819 and 1820:
Topic: F.03.a. Reward Title: The di
Page 1821 and 1822:
Page 1823 and 1824:
levels stabilized (13 cycles), both
Page 1825 and 1826:
during development in the Bengalese
Page 1827 and 1828:
Authors: P. V. LOVELL, *C. V. MELLO
Page 1829 and 1830:
Page 1831 and 1832:
Disclosures: L. Remage-Healey, None
Page 1833 and 1834:
examined behavioral and neural resp
Page 1835 and 1836:
tegmental area (VTA) cell activatio
Page 1837 and 1838:
millisecond before initiation of si
Page 1839 and 1840:
lateral song transmission from tuto
Page 1841 and 1842:
Authors: *B. A. PAWLISCH 1,2 , S. A
Page 1843 and 1844:
Page 1845 and 1846:
number of round DCX-ir cells (diffe
Page 1847 and 1848:
Title: LC/MS/MS analysis of in vivo
Page 1849 and 1850:
previously exposed to novel objects
Page 1851 and 1852:
controlling the adhesion, growth an
Page 1853 and 1854:
MS). Previously this approach had b
Page 1855 and 1856:
Topic: G.01. Molecular, Biochemical
Page 1857 and 1858:
585. Molecular Methods to Monitor a
Page 1859 and 1860:
586. Imaging Techniques VI Location
Page 1861 and 1862:
post injury as compared to that of
Page 1863 and 1864:
apoptosis (1). In the last decade m
Page 1865 and 1866:
Page 1867 and 1868:
such as axons. EdU signal was prese
Page 1869 and 1870:
Page 1871 and 1872:
Aβ. Tissue sections co-stained wit
Page 1873 and 1874:
Support: AEG: Natl. Defense Science
Page 1875 and 1876:
Poster 586. Imaging Techniques VI L
Page 1877 and 1878:
Disclosures: Y. Ogawa, None; K. Osa
Page 1879 and 1880:
Authors: *Z. ZENG 1 , S. O'MALLEY 2
Page 1881 and 1882:
activation, along with the morpholo
Page 1883 and 1884:
vivo. Because co-infectivity of AAV
Page 1885 and 1886:
Authors: *L. C. FLORES, R. GALVEZ,
Page 1887 and 1888:
Authors: J. A. CURRY, A. MOSS, S. T
Page 1889 and 1890:
Authors: *A. E. KALYUZHNY 1 , J. P.
Page 1891 and 1892:
Agence Nationale de Recherche grant
Page 1893 and 1894:
587. Electrophysiological Recording
Page 1895 and 1896:
587. Electrophysiological Recording
Page 1897 and 1898:
procedures allowed the reliable ide
Page 1899 and 1900:
completion IA HA injections. Method
Page 1901 and 1902:
Poster 587. Electrophysiological Re
Page 1903 and 1904:
show all

When citing an abstract from the 2009 Annual - Society for ...

Create successful ePaper yourself

Delete template?

Save as template?